Targeting the STAT Pathway in Head and Neck Cancer: Recent Advances and Future Prospects

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|4|8|637-651

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.4, Iss.8, 2004-12, pp. : 637-651

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [Hot Topic:Recent Advances in Molecular Targeting of Head and Neck Cancer (Guest Editor: Dong Moon Shin, M.D.)]

By  

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-11 ,pp. : 605-605

Bentham Science Publishers

Access to resources Recommend Favorite

Management of Recurrent Head and Neck Cancer: Recent Progress and Future Directions

By Brockstein Bruce E.  

Drugs, Vol. 71, Iss. 12, 2011-08 ,pp. : 1551-1559

Adis International

Access to resources Recommend Favorite

Recent Advances in Combined Modality Therapy for Locally Advanced Head and Neck Cancer

By  

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-11 ,pp. : 674-680

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Angiogenesis in Head and Neck Cancer

By  

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-11 ,pp. : 643-649

Bentham Science Publishers

Access to resources Recommend Favorite

EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer

By  

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-11 ,pp. : 650-665

Bentham Science Publishers

Access to resources Recommend Favorite